# Boston Scientific Corporation (BSX) — Q2-2013 Earnings Results

**Report date:** 2013-07-25 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2013

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Up 12.7%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.18 | N/A | +13.21% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized their commitment to enhancing product offerings.

**Key quotes:**

> Management highlighted strong performance in key product segments.

> They noted ongoing investments in innovation to drive future growth.

### Guidance Changes

No guidance data was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 12.7% increase. The strong EPS performance indicates effective cost management and possibly better-than-expected sales in certain areas. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2013_